Phase <scp>III</scp> randomized clinical trial of <scp>BV</scp>‐4051, an Ayurvedic polyherbal formulation in moderate <scp>SARS‐CoV</scp>‐2 infections and its impact on inflammatory biomarkers
- DOI
- 10.1002/ptr.7683
- Published
- 2022-11-23
- Container
- Phytotherapy Research
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/ptr.7683,
title = {Phase <scp>III</scp> randomized clinical trial of <scp>BV</scp>‐4051, an Ayurvedic polyherbal formulation in moderate <scp>SARS‐CoV</scp>‐2 infections and its impact on inflammatory biomarkers},
author = {Deepa Chitre and Satej Nadkarni and Namdev Jagtap and Rahul Tulle and Amol Gitte and Prashant Rahate and Sunetra Chaskar and Debendranath Dey},
year = {2022},
journal = {Phytotherapy Research},
doi = {10.1002/ptr.7683},
url = {https://doi.org/10.1002/ptr.7683}
}RIS
TY - JOUR TI - Phase <scp>III</scp> randomized clinical trial of <scp>BV</scp>‐4051, an Ayurvedic polyherbal formulation in moderate <scp>SARS‐CoV</scp>‐2 infections and its impact on inflammatory biomarkers AU - Deepa Chitre AU - Satej Nadkarni AU - Namdev Jagtap AU - Rahul Tulle AU - Amol Gitte AU - Prashant Rahate AU - Sunetra Chaskar AU - Debendranath Dey PY - 2022 JO - Phytotherapy Research DO - 10.1002/ptr.7683 UR - https://doi.org/10.1002/ptr.7683 ER -
APA
Chitre, D., Nadkarni, S., Jagtap, N., Tulle, R., Gitte, A., Rahate, P., Chaskar, S., & Dey, D. (2022). Phase <scp>III</scp> randomized clinical trial of <scp>BV</scp>‐4051, an Ayurvedic polyherbal formulation in moderate <scp>SARS‐CoV</scp>‐2 infections and its impact on inflammatory biomarkers. Phytotherapy Research. https://doi.org/10.1002/ptr.7683
Source records
- crossref · retrieved 2026-09-25T04:40:10.583Z